These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6198954)

  • 21. The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells.
    Kang JX; Liu J; Wang J; He C; Li FP
    Carcinogenesis; 2005 Nov; 26(11):1934-9. PubMed ID: 15958519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Receptor system of interferons].
    Yonehara S
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):44-52. PubMed ID: 6320747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4449-54. PubMed ID: 7127287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid.
    Sheikh MS; Shao ZM; Chen JC; Hussain A; Jetten AM; Fontana JA
    J Cell Biochem; 1993 Dec; 53(4):394-404. PubMed ID: 8300756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR).
    Hochmann J
    Neoplasma; 2007; 54(4):290-6. PubMed ID: 17822318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
    King ML; Adler SR; Murphy LL
    Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
    Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
    Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon is a polypeptide hormone.
    Faltynek CR; Baglioni C
    Microbiol Sci; 1984 Jul; 1(4):81-5. PubMed ID: 6086078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of membrane receptors in the biological effects of interferon.
    Chany C; Rousset S; Chany-Fournier F
    Tex Rep Biol Med; 1981-1982; 41():307-12. PubMed ID: 6184818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of liver in the catabolism of human alpha- and beta-interferon.
    Bocci V; Pacini A; Bandinelli L; Pessina GP; Muscettola M; Paulesu L
    J Gen Virol; 1982 Jun; 60(Pt 2):397-400. PubMed ID: 6180128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The strong hydrophobic domain of the activated estrogen receptor of porcine uterus.
    Murayama A; Fukai F
    FEBS Lett; 1983 Jul; 158(2):255-8. PubMed ID: 6873279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species specificity of interferon.
    Gillespie D; Carter WA
    Tex Rep Biol Med; 1981-1982; 41():37-42. PubMed ID: 6184826
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress in the monitoring of human interferon in body fluids and the phenotypic expression of human interferon activity.
    Mitchell WM; Forti RL
    Prog Clin Pathol; 1984; 9():101-19. PubMed ID: 6198690
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved estrogen receptor assay in human mammary cancer. Technics for handling small tissue samples.
    Johnson RB; Nakamura RM
    Am J Clin Pathol; 1977 May; 67(5):444-9. PubMed ID: 855826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure of the human interferon alpha receptor.
    Colamonici OR; Pfeffer LM
    Pharmacol Ther; 1991 Nov; 52(2):227-33. PubMed ID: 1726335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.
    Liu D; Hao Q; Li J; Li Q; Wang K; Geng Q; Wu Y; Vadgama JV; Wu Y
    Cancer Commun (Lond); 2022 Jul; 42(7):663-667. PubMed ID: 35486908
    [No Abstract]   [Full Text] [Related]  

  • 39. Radioimmunoassay for human beta interferon.
    Inoue M; Tan YH
    Infect Immun; 1981 Sep; 33(3):763-8. PubMed ID: 6169643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that types I and II interferons have different receptors.
    Branca AA; Baglioni C
    Nature; 1981 Dec; 294(5843):768-70. PubMed ID: 6172715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.